ThermoGenesis Announces Filing of Patent Applications for Device that Improves the Accuracy of Lateral Flow Immunoassays (LFIA) in the Detection of COVID-19 Antibodies

• NASDAQ: $THMO
• Notified: $6.20
• 08:32 EDT